Government Regulation
'They're being lied to': Oatzempic and the 'false market' of GLP-1 dupes
Products claiming to work like GLP-1s are popular and misleading, but primary care providers can help their patients avoid potentially dangerous supplements, according to experts.
Dietary supplement evidence 'varies widely' with inconsistent regulations
A CDC report published in April 2023 revealed that supplement use commonly occurs in the United States because 58.5% of adults and 34.8% of children and adolescents had used at least one dietary supplement in the past 30 days.
Transgender youths discuss social hostility, isolation due to gender-affirming care bans
Transgender youths discussed social concerns, facing hostility and being worried about losing access to care when interviewed about legislation prohibiting gender-affirming care, according to findings published in LGBT Health.
FDA proposes rule to begin regulating laboratory developed tests
The FDA proposed a rule today to start regulating laboratory developed tests to ensure test safety and effectiveness, the agency said in a press release on Friday.
Illinois, Georgia pass legislation to address vision plan abuses
Illinois and Georgia have passed legislation to protect optometrists from vision plan-enforced discounts and interference in the doctor-patient relationship.
US House committee calls for investigation of vision care consolidation
House Committee on Oversight and Accountability Chairman James Comer requested that the Federal Trade Commission hold a staff-level briefing to discuss the impact of vision care market consolidation on consumers.
Live from Octane OTF 2023
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are live at OCTANe OTF with Mark Leahey, Brent Saunders, Yari Mitchell and Robert Dempsey, discussing their experiences and influence across the ophthalmic space.
Workplace equity, violence top American Nurses Association’s legislative priorities
ORLANDO — Addressing mandatory overtime as well as workplace equity and violence, all amidst a nursing shortage, are among the top legislative priorities for the American Nurses Association, according to a speaker here.
Biden administration proposes rescinding rule on community health center insulin discounts
The Biden administration proposed rescinding a final rule introduced under the Trump administration that would require community health centers to pass on 340B drug discounts for insulin and injectable epinephrine to low-income patients.
Biden administration freezes rule on community health center insulin discounts
The Biden administration issued a temporary freeze on a final rule that would require community health centers to pass on 340B drug discounts for insulin and injectable epinephrine to low-income patients.